- Drug Pipelines
- April 2026
- 280 Pages
Global
From €2775EUR$3,000USD£2,319GBP
- Clinical Trials
- April 2026
- 180 Pages
Global
From €1850EUR$2,000USD£1,546GBP
- Report
- December 2025
- 200 Pages
Global
From €7353EUR$7,950USD£6,145GBP
- Report
- December 2025
- 200 Pages
Global
From €7353EUR$7,950USD£6,145GBP
- Report
- November 2025
- 200 Pages
Global
From €7353EUR$7,950USD£6,145GBP
- Report
- November 2025
- 200 Pages
Global
From €7353EUR$7,950USD£6,145GBP
- Report
- July 2026
- 120 Pages
Global
From €4393EUR$4,750USD£3,672GBP
- Report
- July 2026
- 90 Pages
Global
From €4393EUR$4,750USD£3,672GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2579EUR$2,789USD£2,156GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2579EUR$2,789USD£2,156GBP
- Report
- May 2026
- 200 Pages
Global
From €2579EUR$2,789USD£2,156GBP
- Report
- May 2026
- 100 Pages
Global
From €2496EUR$2,699USD£2,086GBP
- Report
- May 2026
- 100 Pages
Global
From €2496EUR$2,699USD£2,086GBP
- Report
- March 2026
- 400 Pages
Global
From €4577EUR$4,949USD£3,826GBP
- Report
- March 2026
- 150 Pages
Global
From €2496EUR$2,699USD£2,086GBP
- Report
- April 2026
- 305 Pages
Global
From €2312EUR$2,500USD£1,933GBP
- Report
- January 2026
- 286 Pages
Global
From €2312EUR$2,500USD£1,933GBP
- Report
- September 2026
- 150 Pages
Global
From €3468EUR$3,750USD£2,899GBP
- Report
- September 2026
- 150 Pages
Global
From €3468EUR$3,750USD£2,899GBP
- Report
- March 2026
- 150 Pages
Global
From €3468EUR$3,750USD£2,899GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more